Skip to main content
OpenTrials

Clinical trial condition

Immunologic Deficiency Syndromes

Explore clinical trials studying Immunologic Deficiency Syndromes. Study availability and eligibility vary by location and protocol.

6,133 public trials 393 recruiting studies
Refine in advanced search Browse all conditions

Immunologic Deficiency Syndromes trial results

Completed

Innovations in HIV Testing (TI)

NCT03271424

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • Medical Research Council/Wits University Rural Public Health and Health Transitions Research Unit Agincourt, Mpumalanga, South Africa
View Trial Details
Completed

An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis

NCT01772823

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations
  • Children's Hospital of Los Angeles Los Angeles, California, United States
  • University of Colorado - The Children's Hospital of Denver Aurora, Colorado, United States
  • University of Miami Miami, Florida, United States
  • University of South Florida Tampa, Florida, United States
View Trial Details
Completed

An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among 15 to 17 Year Old Young Men Who Have Sex With Men (YMSM)

NCT01769456

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations
  • Children's Hospital of Los Angeles Los Angeles, California, United States
  • University of Colorado - The Children's Hospital of Denver Aurora, Colorado, United States
  • Stroger Hospital of Cook County Chicago, Illinois, United States
  • Tulane Medical Center New Orleans, Louisiana, United States
View Trial Details
Completed

A Dose Ranging Trial of GSK1349572 and 2 NRTI in HIV-1 Infected, Therapy Naive Subjects

NCT00951015

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Bakersfield, California, United States
  • GSK Investigational Site Long Beach, California, United States
  • GSK Investigational Site San Francisco, California, United States
View all 35 locations
View Trial Details
Completed

Dolutegravir Compared to Darunavir/Ritonavir , Each in Combination With Dual Nucleoside Reverse Transcriptase Inhibitors (NRTIs) in ART-naive Subjects

NCT01449929

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Aurora, Colorado, United States
View all 66 locations
View Trial Details

Related conditions